oltipraz has been researched along with (1S,2R)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baird, L; Bertrand, HC; Dinkova-Kostova, AT; Fowkes, A; Georgakopoulos, ND; Kachi, H; Schaap, M; Thiollier, C; Wells, G | 1 |
1 other study(ies) available for oltipraz and (1S,2R)-2-[[(1S)-1-[(1,3-dioxo-2-isoindolyl)methyl]-3,4-dihydro-1H-isoquinolin-2-yl]-oxomethyl]-1-cyclohexanecarboxylic acid
| Article | Year |
|---|---|
Design, Synthesis, and Evaluation of Triazole Derivatives That Induce Nrf2 Dependent Gene Products and Inhibit the Keap1-Nrf2 Protein-Protein Interaction.
Topics: Cell Line, Tumor; Click Chemistry; Computer Simulation; Databases, Chemical; Dose-Response Relationship, Drug; Fluorescence Polarization; HEK293 Cells; Heme Oxygenase-1; Humans; Intracellular Signaling Peptides and Proteins; Isothiocyanates; Kelch-Like ECH-Associated Protein 1; Molecular Docking Simulation; NAD(P)H Dehydrogenase (Quinone); NF-E2-Related Factor 2; Protein Binding; Structure-Activity Relationship; Sulfoxides; Triazoles | 2015 |